Aurora Cannabis ACB shares are trading higher after the company provided a progress update on its previously announced "Business Transformation Plan."
The company said it will exit 2020 at a selling, general & administrative run rate of roughly $42 million and it remains on track for positive adjusted EBITDA in the first quarter of 2021.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis was trading 5.2% higher to $14.42 at the time of publication on Tuesday. The stock has a 52-week high of $95.76 and a 52-week low of $5.30.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
